ClinicalTrials.gg
CompletedNCT07179263Updated Sep 17, 2025

Inducing Redness Clinical Study

An interventional study of 50% glycolic acid and Tape Stripping in Redness, sponsored by ChinaNorm. Completed at 1 site in China. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-17.

Sponsored by ChinaNorm · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Dec 2023, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

This clinical study employs a single-center, split-face, randomized, and on-site controlled design to compare two methods for inducing skin redness (50% Glycolic Acid application and tape stripping) on the face and forearm in a minimum of 40 healthy female subjects. The study involves instrumental measurements (erythema index and a* value), photographic analysis, and expert clinical grading at multiple time points (baseline, 10min, 30min, 1h, 2h, and 4h after induction) to evaluate and compare the efficacy and response profiles of both irritation models.

02

Conditions studied

  • Redness

Browse trials for

03

In context

Erythema

131 studies on the registry are indexed under Erythema; 17 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 114 interventional studies indexed under Erythema.

Browse Erythema studies →

Lead sponsor

ChinaNorm is the lead sponsor of 30 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Chinese female whose age range from 18 to 60 years old;
  2. Be in general good health and good mental state;
  3. Have no any broken, scars, birthmarks and other imperfections on the test area;
  4. Redness/erythema ≥ grade 2 after modelling inducing (to ensure the consistency of the baseline for comparison);
  5. Haven't applied Alpha hydroxyl acid in the past 3 months;
  6. Not currently be participating in any other study involving the test area (Face and Forearm);
  7. Not have participated in any other study involving the test area in the past one month;
  8. Be willing to read, understand and able to sign the Form and Photo Release From;
  9. Be willing to comply with all study protocol requirements.

Exclusion criteria

Exclusion Criteria:

  1. Intending to get pregnant, be pregnant, be lactating, be within 6 months of delivery or be unwilling to take necessary precautions to avoid a pregnancy;
  2. Having used antihistamine drugs in the past 1 week or in the past 1 month;
  3. Take anti-allergic drug/injections in the past 1 month;
  4. Presently have allergies, allergic dermatitis or skin disease;
  5. Have sensitivity or even allergy to topical products, ingredients or fragranced products;
  6. Have history of allergies;
  7. Have history of suffering from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);
  8. Have used any anti-inflammatory treatment on the test area within 2 months prior to this study starting date;
  9. Has a chronic medical condition that may interfere with testing (e.g., asthma, insulin-dependent diabetes, lupus, rheumatoid arthritis or other immune/auto-immune diseases);
  10. Have used any scrubs or peeling product (regardless of method) or self-tanning products or oil control products in the past 3 days;
  11. Have received cosmetic medical procedures on the face (such as injectable anti-wrinkle products, cosmetic surgery, tattoo removal, home light facial procedures or home use medical devices, etc.) in the past 1 month;
  12. Have excessive sun exposure or ultraviolet light in the past 1 month;
  13. Have applied ortho-hydroxybenzoic acid, hydroquinone in the past 3 months; or used prescriptions (such as antibiotic, retinoids, alpha hydroxyl acid and ), oral (such as Diane 35®,Jasmine®, Holgyeme®,Syndi 35®,Regulon®);
  14. Avoid providing emergency contact;
  15. Subjects that are not compliant to the selection criteria or not proper for participation as determined by Principal Investigator;
  16. An employee of the cosmetic companies or Shanghai China-Norm Quality technical service Co., Ltd.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Other
    Facial Test Arm

    Other: 50% glycolic acid · Other: Tape Stripping

  • No intervention
    Facial Control Arm
  • Other
    Arm Test arm

    Other: Tape Stripping

  • No intervention
    Arm control arm

Interventions

  • Other50% glycolic acid

    Subjects use 3 drops about 0.2g of 50% Glycolic Acid product on half face under instruction, then wait for 3 minutes and wash face by tap water. Wait for 10 minutes before measuring.

  • OtherTape Stripping

    Technician use the D100 to paste on the center of the test area and make it fit the skin more completely and evenly by pump fully cover the D100 patch for 10 seconds. Stripping on each test area until the skin change into redness. The number of stripping will be recorded.

06

What researchers measure

Primary outcomes

  1. Change in erythema index by Mexameter® MX 18 (

    Time frame: From baseline to 4-hour after inducing

  2. Change in a* value by Chromameter CM26dG

    The a\*value is a parameter in the CIELAB color space (also known as Lab) that quantifies a color's position along the red-green axis .

    Time frame: From baseline to 4-hour after inducing

  3. Facial Erythema Severity via VISIA-CRP Imaging

    Time frame: From baseline to 4-hour after inducing

  4. Forearm Erythema Intensity via Cross-Polarized Light Imaging

    Time frame: From baseline to 4-hour inducing

07

Study locations

1 site
  • Shanghai China-norm Quality Technical Service Co., Ltd.
    Shanghai, Shanghai Municipality 200072, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07179263
Lead sponsor
ChinaNorm
Responsible party
Sponsor
First posted
Sep 17, 2025
Start date
Dec 22, 2023
Primary completion
Dec 29, 2023
Completion
Dec 29, 2023
Last update
Sep 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion